| Product Code: ETC9959300 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Angioedema Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Angioedema Market - Industry Life Cycle |
3.4 United States (US) Angioedema Market - Porter's Five Forces |
3.5 United States (US) Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 United States (US) Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 United States (US) Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 United States (US) Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 United States (US) Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 United States (US) Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of angioedema in the United States |
4.2.2 Growing awareness about angioedema among healthcare providers and patients |
4.2.3 Technological advancements in the diagnosis and treatment of angioedema |
4.2.4 Rising healthcare expenditure and insurance coverage for angioedema treatments |
4.3 Market Restraints |
4.3.1 High cost of angioedema medications and treatments |
4.3.2 Limited availability of specialized healthcare facilities for angioedema management |
4.3.3 Side effects associated with current angioedema therapies |
4.3.4 Regulatory challenges in drug approval processes for angioedema treatments |
5 United States (US) Angioedema Market Trends |
6 United States (US) Angioedema Market, By Types |
6.1 United States (US) Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 United States (US) Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 United States (US) Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 United States (US) Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 United States (US) Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 United States (US) Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 United States (US) Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 United States (US) Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 United States (US) Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 United States (US) Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 United States (US) Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 United States (US) Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 United States (US) Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 United States (US) Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 United States (US) Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 United States (US) Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 United States (US) Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 United States (US) Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 United States (US) Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 United States (US) Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 United States (US) Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 United States (US) Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 United States (US) Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United States (US) Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 United States (US) Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 United States (US) Angioedema Market Import-Export Trade Statistics |
7.1 United States (US) Angioedema Market Export to Major Countries |
7.2 United States (US) Angioedema Market Imports from Major Countries |
8 United States (US) Angioedema Market Key Performance Indicators |
8.1 Number of patients diagnosed with angioedema annually |
8.2 Rate of adoption of new angioedema treatment technologies |
8.3 Patient satisfaction levels with angioedema management services |
8.4 Research and development investment in new angioedema therapies |
8.5 Healthcare provider training and education programs on angioedema |
9 United States (US) Angioedema Market - Opportunity Assessment |
9.1 United States (US) Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 United States (US) Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 United States (US) Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 United States (US) Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 United States (US) Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 United States (US) Angioedema Market - Competitive Landscape |
10.1 United States (US) Angioedema Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here